In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes


Yılmaz G., Çelik S., Özel A., Akyüz S.

European Journal of Biology, cilt.1, sa.1, ss.1-8, 2024 (Scopus) identifier